Among the 35 MiT family translocation renal cell carcinomas tested, AMACR, instead, stained positive in 26 (74%), 19 (54%), and 18 cases (51%), regarding a 5%, 10%, and 20% cutoff respectively. The gene discussed is AMACR; the disease is renal cell carcinoma.